Our commitment to continuing to innovate in cancer care is reflected in our latest data. At #ASH24 and #SABCS24, we will be sharing new results in adults with newly diagnosed chronic myeloid leukemia and early breast cancer, as well as highlighting advancements in our research and development programs in oncology. #NovartisUS #ReimaginingMedicine
Novartis US
制药业
East Hanover，New Jersey 101,321 位关注者
Transforming people’s lives by reimagining medicine.
关于我们
At Novartis US, our mission is to reimagine medicine and discover new ways to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. Novartis products reach nearly 800 million people globally and we are finding innovative ways to provide solutions to address the evolving needs of patients. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Over 41% of global Novartis R&D expenditure ($3.9 billion) was invested in the US in 2019. Our US presence is comprised of nearly 15,000 employees, with campuses across the country including in East Hanover, NJ, Cambridge, MA, and Indianapolis, IN. See our community guidelines: https://bit.ly/2JnT2CP
- 网站
-
https://www.novartis.us/
Novartis US的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- East Hanover，New Jersey
- 创立
- 1996
- 领域
- Research、Innovation、Quality、Sustainability、Innovative Medicines、Generic Medicines and Biosimilars、Unique Portfolio Focuses & Broad Healthcare Portfolio、Cell & Gene Therapy和Data & Digital
动态
-
Joining experts in the field, patients and advocacy partners, our teams recently attended the American College of Rheumatology's Convergence 2024 Conference in Washington D.C., to discuss the latest research and developments in treating rheumatic conditions. Meet Anne Fountain and Lindsay Hall, two Novartis associates from our US Patient Advocacy team, who shared reflections from their experience at #ACR24. “A highlight of my first ACR experience was connecting with patient advocacy partners at the conference to discuss our shared priorities and ultimately pollinate new ideas and projects that will benefit patients,” shares Anne. “The full impact of diseases like lupus or Sjogren’s disease are underrecognized and under characterized, reinforcing the vital role that patient advocacy plays in ensuring that the patient voice is heard to shape the future of rheumatology.” “While we still have a lot of work to accomplish in tackling immunological conditions, I’m inspired by the progress in drug innovation and growth in our basic understanding of these diseases,” shares Lindsay. “My time at ACR has reminded me how complex and debilitating these diseases can become for patients and has reinvigorated me to lean in harder than before in working more innovatively with our patient advocacy partners.” Reflecting on their experiences and what this means at Novartis, it’s a reminder of why we keep patient voices at the center of everything we do as we continuously work to reimagine medicine. #ACR24
-
-
This past weekend at #AHA24, our team joined together with leading voices in the #cardiovasculardisease community to celebrate the latest scientific advancements. At Novartis, we’re proud of the positive impact we’ve made over the past 40 years and remain dedicated to tackling the most challenging problems in cardiovascular disease. By working together, we can help people living with this disease enjoy longer, healthier lives and ensure no heart is lost too soon.
-
-
When it comes to cardiovascular disease, a key priority of ours is to listen, learn, and collaborate with the most important voices in the fight against this disease— people living with cardiovascular disease, patient advocacy organizations, professional societies, and healthcare professionals. Today in Chicago we brought many of these experts together for an honest conversation about unmet needs and patient support opportunities for those living with #cardiovasculardisease. Thank you to all who participated in this engaging and inspiring session. Together, we can help people living with cardiovascular disease enjoy longer, healthier lives and cherish precious moments with their loved ones. #AHA24 Black Heart Association The Mended Hearts, Inc. Global Coalition on Aging National Minority Quality Forum HealthyWomen Caregiver Action Network Vasculearn Network WomenHeart: The National Coalition for Women with Heart Disease Society for Cardiovascular Angiography & Interventions Sam Knowles - Master Data Storyteller
-
-
Millions of people experience cardiovascular (CV) events every year, but these aren’t just numbers. They’re our loved ones, our friends, our colleagues, and even ourselves. Our SVP and TA Head of Cardiovascular, Renal & Metabolic Dianne Auclair Rocha recently shared her story about experiencing first-hand the impact of CV disease on her family. Read on to hear how our Heads of our Cardiovascular, Renal and Metabolic business talk through their strategy of focusing on prevention through early screening, education, partnerships, and empowering patients to voice their needs.
Novartis is on a mission to break down barriers to cardiovascular, renal, and metabolic (CRM) treatments through empathy, access, and innovation. In a recent interview, Dianne Auclair Rocha, SVP and TA Head, Cardiovascular, Renal and Metabolic in the US and Vasilisa Sazonov, Therapy Area Head Cardiovascular, Renal, Metabolic internationally talked about their focus on prevention through education, early screening efforts, and partnerships to reduce access barriers for patients. The leaders emphasized the importance of understanding patient needs and fostering a patient-centered approach, as well as the role of personalized medicine and digital health in the future. Hear more about these leaders' perspectives on the importance of tackling the challenges in the cardiovascular, renal and metabolic space in the article: https://lnkd.in/gTaQHTEJ
-
It was an honor to have been recognized at the 2024 #PrixGalien USA Awards for our groundbreaking work in advancing radioligand therapy, transforming cancer care and improving patient outcomes. Thank you to The Galien Foundation for the nomination of Best Pharmaceutical Product and recognizing the potential of #radioligandtherapy as we are #ReimaginingMedicine.
-
-
People with chronic myeloid leukemia (CML) deserve more treatment options—ones that offer efficacy and a tolerability profile that may work for them. Our latest milestone may give patients the opportunity to pursue that reality. #ReimaginingMedicine
-
This past weekend, we had the pleasure of attending and presenting at American Society of Nephrology #KidneyWk 2024 in San Diego. Our team joined leading nephrology professionals, physicians, and advocates by sharing the latest scientific and medical advancements in the field. We are grateful for the opportunity to collaborate and engage in impactful conversations with this community. At Novartis, our journey in nephrology began more than 40 years ago and today, we continue to advance a broad renal R&D portfolio with the aim to help transform the lives of people living with kidney diseases.
-
-
This #BreastCancerAwarenessMonth, we are proud to support our advocacy group partners in their efforts to drive meaningful change in the breast cancer community. Our Patient Advocacy Team and Cancer Hope Employee Resource Group (ERG) partnered to host Unite for HER on our East Hanover campus, whose team helped us lead an incredible “Care Box Build” event. Unite for HER supports breast cancer patients across the nation by providing integrative therapies, services, education, resources and more. Their care boxes are designed to help bring balance to patients’ emotional and physical well-being during treatment and beyond. With the help of over 50 Novartis volunteers, we built 500 care boxes – 200 of which were shipped out to patients just days following the event. Boxes contained a variety of supportive items from self-care items to educational materials. Thank you to our Novartis volunteers for your support and Unite for HER for all you do for the breast cancer community!
-